Comparison of two drug for poly cystic ovary

Comparison the effect of Metformin and Chromium picolinate on pregnancy rate in Clomiphene Citrate-Resistant Polycystic Ovary Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201203139281N1

Enrollment

Registered

2012-06-14

Start date

2009-01-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility. Female infertility associated with anovulation

Interventions

Intervention 1: In first group patients take1500mg/day metformine in 3 divided dosage. Intervention 2: In second group patients take chromium picolinate200mcg /day.

Treatment - Drugs

In first group patients take1500mg/day metformine in 3 divided dosage

In second group patients take chromium picolinate200mcg /day

Eligibility

Sex/Gender

Female

Age

15 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: poly cystic ovaries;clomiphene resistant ;infertile. Exclusion .criteria:any medical disease like diabetes;Cushing’s syndrome; hyperprolactinemia ; thyroid disease ; other endocrinopathies ; oral contraceptives (OCPs); any medications that interfere with lipid metabolism.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pregnancy rate. Timepoint: 3 months after starting. Method of measurement: pregnancy test.	—

Secondary

Measure	Time frame
Pateint telorance testestron. Timepoint: each month. Method of measurement: lab data questioare.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSedigheh Amooee

Shiraz University of Medical Sciences

sedighehamooee@gmail.com+98 71 1233 2365

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026